MNTK vs. BEAM

Last updated Aug 1, 2026

MNTK (Montauk Renewables, Inc.) and BEAM (Beam Therapeutics Inc.) are both stocks. MNTK operates in Utilities - Diversified (Utilities), while BEAM operates in Biotechnology (Healthcare). Over the past 5 years, MNTK returned -24.52%/yr vs -22.62%/yr for BEAM. Their 0.28 correlation means their historical movements had little consistent relationship.

Performance

MNTK vs. BEAM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Montauk Renewables, Inc. (MNTK) and Beam Therapeutics Inc. (BEAM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MNTK achieves a 2.40% return, which is significantly higher than BEAM's -7.94% return.

MNTK

• 1D: -6.56%
• 1M: 1.18%
• 6M: -1.72%
• YTD: 2.40%
• 1Y: -16.99%
• 3Y*: -41.66%
• 5Y*: -24.52%
• 10Y*: —
• ALL TIME*: -30.75%

BEAM

• 1D: -3.66%
• 1M: -26.65%
• 6M: -7.60%
• YTD: -7.94%
• 1Y: 35.53%
• 3Y*: -3.63%
• 5Y*: -22.62%
• 10Y*: —
• ALL TIME*: 0.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
BEAM Beam Therapeutics Inc.	$49.96M	$71.79M	$70.50M
MNTK Montauk Renewables, Inc.	$438.83K	$317.98K	$348.54K

MNTK vs. BEAM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
MNTK Montauk Renewables, Inc.	2.40%	-58.04%	-55.33%	-19.22%	7.61%	-21.15%
BEAM Beam Therapeutics Inc.	-7.94%	11.77%	-8.89%	-30.40%	-50.92%	-13.97%

Correlation

The correlation between MNTK and BEAM is 0.12, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.12
Correlation (3Y) Balances recent behavior with more history.	0.27
Correlation (5Y) Shows whether the relationship held over a longer period.	0.29
Correlation (All Time) Calculated using the full available price history since Jan 22, 2021	0.28

The correlation between MNTK and BEAM shifts across timeframes, from 0.12 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap MNTK : $243.40M BEAM : $2.63B
EPS MNTK : $0.02 BEAM : -$0.63
PS Ratio MNTK : 0.91 BEAM : 19.99
Total Revenue (TTM) MNTK : $180.21M BEAM : $132.27M
Gross Profit (TTM) MNTK : $51.29M BEAM : -$84.92M
EBITDA (TTM) MNTK : $36.19M BEAM : -$68.39M

Return for Risk

MNTK vs. BEAM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MNTK

MNTK Risk / Return Rank: 33
MNTK Sharpe Ratio Rank: 32
MNTK Sortino Ratio Rank: 35
MNTK Omega Ratio Rank: 34
MNTK Calmar Ratio Rank: 31
MNTK Martin Ratio Rank: 32

BEAM

BEAM Risk / Return Rank: 62
BEAM Sharpe Ratio Rank: 59
BEAM Sortino Ratio Rank: 64
BEAM Omega Ratio Rank: 60
BEAM Calmar Ratio Rank: 63
BEAM Martin Ratio Rank: 63

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MNTK vs. BEAM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Montauk Renewables, Inc. (MNTK) and Beam Therapeutics Inc. (BEAM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MNTK	BEAM	Difference
Sharpe ratio: Return per unit of total volatility	-0.29	0.39	-0.68
Sortino ratio: Return per unit of downside risk	0.06	1.20	-1.13
Omega ratio: Gain probability vs. loss probability	1.01	1.13	-0.12
Calmar ratio: Return relative to maximum drawdown	-0.39	0.78	-1.16
Martin ratio: Return relative to average drawdown	-0.66	1.64	-2.30

MNTK vs. BEAM - Sharpe Ratio Comparison

The current MNTK Sharpe Ratio is -0.29, which is lower than the BEAM Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of MNTK and BEAM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

MNTK vs. BEAM - Drawdown Comparison

The maximum MNTK drawdown since its inception was -94.49%, which is greater than BEAM's maximum drawdown of -89.12%. Use the drawdown chart below to compare losses from any high point for MNTK and BEAM.

Drawdown Indicators

	MNTK	BEAM	Difference
Max Drawdown Largest peak-to-trough decline	-94.49%	-89.12%	-5.37%
Max Drawdown (1Y) Largest decline over 1 year	-54.84%	-38.15%	-16.69%
Max Drawdown (3Y) Largest decline over 3 years	-89.61%	-67.74%	-21.87%
Max Drawdown (5Y) Largest decline over 5 years	-94.49%	-87.25%	-7.24%
Current Drawdown Current decline from peak	-91.58%	-80.90%	-10.68%
Average Drawdown Average peak-to-trough decline	-58.30%	-60.22%	+1.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	32.36%	18.14%	+14.22%

Volatility

MNTK vs. BEAM - Volatility Comparison

The current volatility for Montauk Renewables, Inc. (MNTK) is 16.64%, while Beam Therapeutics Inc. (BEAM) has a volatility of 18.78%. This indicates that MNTK experiences smaller price fluctuations and is considered to be less risky than BEAM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MNTK	BEAM	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.64%	18.78%	-2.14%
Volatility (6M) Calculated over the trailing 6-month period	46.85%	49.97%	-3.12%
Volatility (1Y) Calculated over the trailing 1-year period	73.99%	75.16%	-1.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.60%	75.00%	-2.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.96%	80.54%	-7.58%

Dividends

MNTK vs. BEAM - Dividend Comparison

Neither MNTK nor BEAM has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both MNTK and BEAM in my portfolio?

MNTK and BEAM have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MNTK or BEAM?

BEAM has higher volatility (18.78%) compared to MNTK (16.64%). In terms of maximum drawdown, MNTK dropped -94.49% vs BEAM's -89.12%.

Which has better risk-adjusted returns?

BEAM currently has the higher Sharpe Ratio (0.39 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.